European Union - English - EMA (European Medicines Agency)

advanced accelerator applications - l-arginine hydrochloride, l-lysine hydrochloride - radiation injuries - detoxifying agents for antineoplastic treatment - lysakare is indicated for reduction of renal radiation exposure during peptide-receptor radionuclide therapy (prrt) with lutetium (177lu) oxodotreotide in adults.

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - l-arginine hydrochloride; l-lysine hydrochloride - infusion, solution - l-arginine hydrochloride 25 g/l; l-lysine hydrochloride 25 g/l

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - l-arginine monohydrochloride; l-lysine monohydrochloride - infusion - 25mg/1ml ; 25mg/1ml